Phase 2 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with type 2 diabetes
- People with a body mass index (BMI) between 25 and 39.9 (a measure of body weight relative to height)
- People whose blood sugar control levels, measured by a test called HbA1c, fall between 6.5% and 10.5%
- People who have been taking a steady, unchanged dose of metformin (a common diabetes medication)
Who may not be able to join:
- People who have another serious illness, health condition, or unusual test results that could affect their safety during the trial or make the results harder to interpret
- People who are currently taking medications that are known to affect how the body processes sugar or insulin, other than their existing type 2 diabetes treatments or contraceptives (birth control)
- There may be additional criteria not listed here that the trial site will assess (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Alnylam Pharmaceuticals
Phone: 1-877-ALNYLAM
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in M-value
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.